GCVTX | RMFCX | GCVTX / RMFCX | |
Total Expense Ratio | 0.67 | 0.91 | 74% |
Annual Report Gross Expense Ratio | 0.77 | 0.91 | 85% |
Fund Existence | 18 years | 23 years | - |
Gain YTD | 6.587 | 11.347 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 539M | 111B | 0% |
Annual Yield % from dividends | 1.10 | 1.27 | 86% |
Returns for 1 year | -1.74 | 11.38 | -15% |
Returns for 3 years | 21.22 | 30.87 | 69% |
Returns for 5 years | 34.30 | 60.49 | 57% |
Returns for 10 years | 61.42 | 81.82 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMBD | 23.28 | 0.10 | +0.43% |
Global X Emerging Markets Bond ETF | |||
FMED | 24.15 | 0.06 | +0.26% |
Fidelity Disruptive Medicine ETF | |||
AGG | 98.45 | 0.16 | +0.16% |
iShares Core US Aggregate Bond ETF | |||
UBR | 19.03 | N/A | N/A |
ProShares Ultra MSCI Brazil Capped | |||
CGIE | 33.09 | -0.07 | -0.21% |
Capital Group International Equity ETF |